"Designing Growth Strategies is in our DNA"

Morquio Syndrome Treatment Market Size, Share and Global Trend By Treatment (Enzyme Replacement Therapy), By Disease Type (Morquio A, Morquio B), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Regional Forecast, 2024-2032

Region :Global | Report ID: FBI100202 | Status : Ongoing



Morquio Syndrome, also known as MPS IV and mucopolysaccharidosis IV, refers to a rare inherited metabolic disorder or birth defect that mostly affects the skeleton. The FDA approval of VIMIZIM (elosulfase alpha), the first and the only specific treatment for the patients with this ultra-rare genetic condition, firmly established BioMarin’s position as a leading market player for the treatment of MPS diseases.

Apart from the recent regulatory approvals, there has been increasing activity in the R&D for the Morquio syndrome treatment as evidenced by the greater inclusion of the disorder in the clinical pipelines of the major market players. For instance, Ultragenyx Pharmaceutical Inc. has a Phase 3 Study undergoing for the Morquio syndrome, Shire has an ongoing clinical trial for the pediatric patients suffering from the syndrome and ArmaGen, Inc. also has a drug (AGT-181) in the clinical trials. This combined with the greater awareness of the disease is also driving the growth in Morquio syndrome treatment market.

To gain extensive insights into the market, Request for Customization

The growth in the number of products in the preliminary and advanced stages of R&D along with the focus on treatment of rare diseases is anticipated to drive the growth in the Morquio syndrome treatment market at a considerably fast rate. With the recent approval of the elosulfase alpha (VIMIZIM), the market is expected to be boosted a number of products currently in the pipelines of various companies can be anticipated to undergo regulatory approvals for the marketing, if they have favourable clinical trials results. 

The factor that is expected to limit the growth of the market is the huge price tag associated with Morquio syndrome treatment products. For example, VIMIZIM is expected to cost patients around US$ 380,000, which is estimated to be the product’s annual cost. Other factors which may limit the growth of the market is the lack of awareness in the emerging markets and the regulatory and the clinical hurdles. 

Key Players Covered 

Some of the major companies that are present in the global Morquio Syndrome Treatment Market are BioMarin, Genzyme Corporation, Shire, JCR Pharmaceuticals Co., Ltd., Sanofi, Sangamo Therapeutics, ArmaGen and GREEN CROSS CORP, Concert Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., and other players. 





By Treatment

·      Enzyme Replacement Therapy

·      Others

By Disease Type

·      Morquio A

·      Morquio B

ByDistribution Channel

·      Hospital Pharmacies

·      Retail Pharmacies

·      Online Pharmacies

·      Others

By Geography

·      North America (USA and Canada)

·      Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

·      Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

·      Latin America (Brazil, Mexico and Rest of Latin America)

·      Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)


At present, enzyme replacement therapy accounts for the largest proportion of the market and the trend is expected to remain same during the forecast period due to the approval of elosulfase alpha, the only FDA approved treatment option, is an enzyme replacement therapy. 

Key Insights 

  • Prevalence of Morquio syndrome by key countries

  • Advancements in research & development of treatment options

  • Overview of advancements in novel therapeutics

  • Pricing Analysis by key countries

  • Pipeline Analysis

  • Regulatory scenario by key countries

  • New product launches 

Regional Analysis 

The global Morquio Syndrome Treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America followed by Europe are the two largest markets for Morquio Syndrome Treatment at present and they are expected to account for a large proportion of the market in the forecast period as well. The world’s first and only Morquio Syndrome Treatment, VIMIZIM, received marketing approval in the U.S. and Europe in 2014 and as of date, this is the only specific treatment for Morquio syndrome that is approved by the regulatory authorities. In the Asia Pacific region, Japan is expected to provide the largest market opportunity. This was primarily due to the early approval and adoption of VIMIZIM as a treatment option for the Morquio syndrome. 

Key Industry Developments

  • In 2014, Bio Marin’s product offering of VIMIZIM (elosulfase alpha) was approved as the only treatment option for Morquio syndrome across a number of regulatory agencies in the U.S., Europe and Japan

  • In 2017, Sangamo Therapeutics Inc., who have the gene therapy candidate (SB-913) in their clinical pipeline, was granted the rare pediatric disease designation from the FDA

  • Another drug from Sangamo, SB-318 was also granted the orphan drug status from the U.S. FDA 

  • Ongoing
  • 2023
  • 2019-2022

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients


Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.